{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:57:33Z","timestamp":1791496653739,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1002\/jps.23146","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T19:59:01Z","timestamp":1333569541000},"page":"2271-2280","source":"Crossref","is-referenced-by-count":293,"title":["Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles"],"prefix":"10.1016","volume":"101","author":[{"given":"Dimitrios","family":"Psimadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varvara","family":"Valotassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Loudos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23146_bb0010","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2967\/jnumed.108.053041","article-title":"Peptide-based probes for cancer imaging","volume":"49","author":"Reubi","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/cbr.2005.20.163","article-title":"Molecular nuclear imaging: The radiopharmaceuticals","volume":"20","author":"Imam","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1002\/jps.23146_bb0020","series-title":"Holland-Frei Cancer Medicine","article-title":"Radionuclide imaging in cancer medicine","author":"Hawkins","year":"2000"},{"key":"10.1002\/jps.23146_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1101\/gad.1047403","article-title":"Molecular imaging in living subjects: Seeing fundamental biological processes in a new light","volume":"17","author":"Massoud","year":"2002","journal-title":"Genes Dev"},{"key":"10.1002\/jps.23146_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0733-8651(18)30109-7","article-title":"Dual-isotope myocardial perfusion SPECT with rest thallium-201 and stress Tc-99m sestamibi","volume":"12","author":"Berman","year":"1994","journal-title":"Cardiol Clin"},{"key":"10.1002\/jps.23146_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-409X(98)00093-3","article-title":"Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis","volume":"37","author":"Cutler","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23146_bb0040","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/cr980451q","article-title":"Radiometal-labeled agents (non-technetium) for diagnostic imaging","volume":"99","author":"Anderson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1002\/jps.23146_bb0045","first-page":"222","article-title":"Radiometal complexes: Characterization and relevant in vitro studies","volume":"52","author":"Jurisson","year":"2008","journal-title":"Q J Nucl Med"},{"key":"10.1002\/jps.23146_bb0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14737140.7.6.833","article-title":"Nanotechnology for targeted cancer therapy","volume":"7","author":"Wang","year":"2007","journal-title":"Exp Rev Anticancer Ther"},{"issue":"1","key":"10.1002\/jps.23146_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-3155-2-12","article-title":"Nanoparticles\u2014Known and unknown health risks","volume":"2","author":"Hoet","year":"2004","journal-title":"J Nanobiotechnology"},{"key":"10.1002\/jps.23146_bb0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2310\/7290.2010.00031","article-title":"Nanoparticles for biomedical imaging: Fundamentals of clinical translation","volume":"9","author":"Choi","year":"2010","journal-title":"Mol Imaging"},{"key":"10.1002\/jps.23146_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1748-0132(07)70083-X","article-title":"Targeted nanoparticles for cancer therapy","volume":"2","author":"Gu","year":"2007","journal-title":"NanoToday"},{"key":"10.1002\/jps.23146_bb0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jps.1023","article-title":"Trends and developments in liposome drug delivery systems","volume":"90","author":"Lian","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23146_bb0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.addr.2011.03.008","article-title":"Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery","volume":"63","author":"Kumar","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23146_bb0080","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1039\/c0dt00689k","article-title":"Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment","volume":"40","author":"Schladt","year":"2011","journal-title":"Dalton Trans"},{"key":"10.1002\/jps.23146_bb0085","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23146_bb0090","first-page":"193","article-title":"Tumoritropic and lymphotropic principles of macromolecular drugs","volume":"6","author":"Maeda","year":"1989","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1002\/jps.23146_bb0095","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1021\/nn800716j","article-title":"Composite nanoparticles take aim at cancer","volume":"2","author":"Gil","year":"2008","journal-title":"ACS Nano"},{"key":"10.1002\/jps.23146_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0163-7827(00)00013-8","article-title":"Radiolabeled liposomes for scintigraphic imaging","volume":"39","author":"Boerman","year":"2000","journal-title":"Progr Lipid Res"},{"key":"10.1002\/jps.23146_bb0105","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric microspheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1002\/jps.23146_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0005-2736(93)90039-3","article-title":"Specific targeting with poly(ethylene glycol)-modified liposomes: Coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times","volume":"1149","author":"Blume","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.23146_bb0115","first-page":"297","article-title":"Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"10.1002\/jps.23146_bb0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2007.03.012","article-title":"Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody","volume":"120","author":"Kocbek","year":"2007","journal-title":"J Control Release"},{"key":"10.1002\/jps.23146_bb0125","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.22709","article-title":"Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles","volume":"120","author":"Liu","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1002\/jps.23146_bb0130","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2967\/jnumed.108.051243","article-title":"PET\/MRI dual-modality tumor imaging using arginine\u2013glycine\u2013aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles","volume":"49","author":"Lee","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0135","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2967\/jnumed.106.039131","article-title":"Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes","volume":"48","author":"McDevitt","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2008.05.024","article-title":"Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging?","volume":"130","author":"Saad","year":"2008","journal-title":"J Control Release"},{"key":"10.1002\/jps.23146_bb0145","first-page":"267","article-title":"Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles","volume":"52","author":"Shokeen","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1002\/jps.23146_bb0150","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00259-009-1104-2","article-title":"Nanoparticles for concurrent multimodality imaging and therapy: The dawn of new theragnostic synergies","volume":"36","author":"Lucignani","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1002\/jps.23146_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08982100601186474","article-title":"Antinucleosome antibody-modified liposomes and lipidcore micelles for tumor-targeted delivery of therapeutic and diagnostic agents","volume":"17","author":"Elbayoumi","year":"2007","journal-title":"J Liposome Res"},{"key":"10.1002\/jps.23146_bb0160","doi-asserted-by":"crossref","first-page":"953537","DOI":"10.1155\/2010\/953537","article-title":"Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy","volume":"2010","author":"Ting","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1002\/jps.23146_bb0165","first-page":"187","article-title":"Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine","volume":"11","author":"Arulsudar","year":"2003","journal-title":"J Drug Target"},{"key":"10.1002\/jps.23146_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0169-409X(98)00095-7","article-title":"Liposomes for scintigraphic detection of infection and inflammation","volume":"37","author":"Laverman","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23146_bb0175","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00259-006-0139-x","article-title":"Enhanced accumulation of long-circulating liposomes modified with thenucleosome-specific monoclonal antibody 2C5 in various tumours in mice: Gamma-imaging studies","volume":"33","author":"Elbayoumi","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1002\/jps.23146_bb0180","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ijrobp.2003.10.057","article-title":"A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles","volume":"58","author":"Li","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1002\/jps.23146_bb0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6446(03)02623-0","article-title":"Peptide and protein drug delivery to and into tumors: Callenges and solutions","volume":"8","author":"Torchilin","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1002\/jps.23146_bb0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/08982100903311812","article-title":"Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: A comparison using different radiometals","volume":"20","author":"Helbok","year":"2010","journal-title":"J Liposome Res"},{"key":"10.1002\/jps.23146_bb0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.109.069880","article-title":"A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer","volume":"51","author":"Hwang do","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.nucmedbio.2008.03.003","article-title":"Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer","volume":"35","author":"Chakraborty","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1002\/jps.23146_bb0205","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.addr.2008.04.013","article-title":"Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer","volume":"60","author":"Hamoudeh","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23146_bb0210","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.addr.2008.03.014","article-title":"Multifunctional magnetic nanoparticles for targeted imaging and therapy","volume":"60","author":"McCarthy","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23146_bb0215","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nantod.2009.07.001","article-title":"Molecular imaging and therapy of cancer with radiolabeled nanoparticles","volume":"4","author":"Hong","year":"2009","journal-title":"Nano Today"},{"key":"10.1002\/jps.23146_bb0220","unstructured":"Psimadas D, Baldi G, Ravagli C, Bouziotis P, Xanthopoulos S, Franchini MC, Georgoulias P, Loudos G.Preliminary evaluation of a 99mTc labeled hybrid nanoparticle bearing a cobalt ferrite core: in vivo biodistribution. J Biomed Nanotechnol (in press)."},{"key":"10.1002\/jps.23146_bb0225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejrad.2010.06.025","article-title":"Current status and future perspectives of in vivo small animal imaging using radiolabeled nanoparticles","volume":"78","author":"Loudos","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1002\/jps.23146_bb0230","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.nucmedbio.2008.04.001","article-title":"Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29\/luc-bearing animal model","volume":"35","author":"Chow","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1002\/jps.23146_bb0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nima.2006.08.135","article-title":"Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29\/luc mouse xenografts","volume":"569","author":"Lee","year":"2006","journal-title":"Nucl Instr Methods Phys Res"},{"key":"10.1002\/jps.23146_bb0240","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.biomaterials.2011.04.070","article-title":"Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1002\/jps.23146_bb0245","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2967\/jnumed.110.083220","article-title":"Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis","volume":"52","author":"Zhang","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0250","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s11095-010-0068-z","article-title":"in vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23146_bb0255","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/mp100038h","article-title":"The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles","volume":"7","author":"Lee","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.23146_bb0260","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jps.20813","article-title":"Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice","volume":"96","author":"Kommareddy","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23146_bb0265","first-page":"437","article-title":"Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice","volume":"48","author":"DeNardo","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0270","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/1535-7163.MCT-08-0016","article-title":"in vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy","volume":"7","author":"Melancon","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jps.23146_bb0275","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1073\/pnas.0509009103","article-title":"Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers","volume":"103","author":"Singh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jps.23146_bb0280","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/ijc.22581","article-title":"Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles","volume":"120","author":"Hu","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1002\/jps.23146_bb0285","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2967\/jnumed.108.056366","article-title":"Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In","volume":"50","author":"Liu","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0290","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/MNM.0b013e32832f2b59","article-title":"Biodistribution study and identification of inflammatory sites using nanocapsules labeled with (99m)Tc-HMPAO","volume":"9","author":"Pereira","year":"2009","journal-title":"Nucl Med Commun"},{"key":"10.1002\/jps.23146_bb0295","series-title":"Radioactive Decay Data Tables-A Handbook of Decay Data for Application to Radiation Dosimetry and Radiological Assessments, DOE\/TIC-11026","first-page":"115","author":"Kocher","year":"1981"},{"key":"10.1002\/jps.23146_bb0300","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2174\/1381612023393756","article-title":"Experience with indium-111 and yttrium-90-labeled somatostatin analogs","volume":"8","author":"Virgolini","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1002\/jps.23146_bb0305","first-page":"21","article-title":"Macrocyclic chelates of radiometals for diagnosis and therapy","volume":"10","author":"Meares","year":"1990","journal-title":"Br J Cancer Suppl"},{"key":"10.1002\/jps.23146_bb0310","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1126\/science.7871422","article-title":"Liposomes revisited","volume":"267","author":"Lasic","year":"1995","journal-title":"Science"},{"key":"10.1002\/jps.23146_bb0315","first-page":"480","article-title":"Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. I. Soluble agents","volume":"17","author":"McAfee","year":"1976","journal-title":"J Nucl Med"},{"key":"10.1002\/jps.23146_bb0320","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jps.2600780613","article-title":"Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice","volume":"78","author":"Rolland","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23146_bb0325","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1389201003378960","article-title":"Polymeric contrast agents for medical imaging","volume":"1","author":"Torchilin","year":"2000","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1002\/jps.23146_bb0330","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915315276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915315276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T22:52:24Z","timestamp":1561589544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915315276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0022354915315276"],"URL":"https:\/\/doi.org\/10.1002\/jps.23146","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}